ConductScience.org, home

Paper19945296

Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.

Venkataswamy MM and 1 other. Semin Immunol, 2010. Cited by 103 papers, by iCite.

Cite this record

ConductScience Library. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Papers, record 19945296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19945296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
PubMed
Journal
Semin Immunol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
103
iCite
Relative citation ratio, by iCite
2.29
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Venkataswamy MMManjunatha M
2Porcelli SASteven A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, BacterialMajor topic
Antigens, ProtozoanMajor topic
AutoantigensMajor topic
GlycolipidsMajor topic
Natural Killer T-CellsMajor topic
Animals
Antigens, CD1d
Humans
Immunity, Innate
Immunomodulation
Ligands
Lymphocyte Activation
Receptors, Antigen, T-Cell
T-Cell Antigen Receptor Specificity

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI063537NIAID NIH HHSUnited StatesP01AI063537PubMed and NIHNIH RePORTER
R01 AI045889NIAID NIH HHSUnited StatesR01AI045889PubMed and NIHNIH RePORTER
AI063537NIAID NIH HHSUnited StatesP01AI063537PubMed and NIHNIH RePORTER
AI45889NIAID NIH HHSUnited StatesR01AI045889PubMed and NIHNIH RePORTER

Download CSV of grants

References97

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118295796Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.J Mol Biol2008https://conductscience.org/library/papers/18295796PubMed
218635002Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells.Chem Biol2008https://conductscience.org/library/papers/18635002PubMed
319160440Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants.ChemMedChem2009https://conductscience.org/library/papers/19160440PubMed
414684827Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.Science2004https://conductscience.org/library/papers/14684827PubMed
512576547Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12576547PubMed
610974039Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.J Exp Med2000https://conductscience.org/library/papers/10974039PubMed
715356115Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.J Immunol2004https://conductscience.org/library/papers/15356115PubMed
819620317Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin.J Immunol2009https://conductscience.org/library/papers/19620317PubMed
914634090MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype.J Immunol2003https://conductscience.org/library/papers/14634090PubMed
108866665KRN7000, a novel immunomodulator, and its antitumor activities.Oncol Res1995https://conductscience.org/library/papers/8866665PubMed
1114707067Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.J Immunol2004https://conductscience.org/library/papers/14707067PubMed
1217660835Synthesis and evaluation of stimulatory properties of Sphingomonadaceae glycolipids.Nat Chem Biol2007https://conductscience.org/library/papers/17660835PubMed
1312847141Cross-presentation of disialoganglioside GD3 to natural killer T cells.J Exp Med2003https://conductscience.org/library/papers/12847141PubMed
1411158680Glycolipid antigen processing for presentation by CD1d molecules.Science2001https://conductscience.org/library/papers/11158680PubMed
1517593657Structure and biology of self lipid antigens.Curr Top Microbiol Immunol2007https://conductscience.org/library/papers/17593657PubMed
1617581592CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.Nature2007https://conductscience.org/library/papers/17581592PubMed
1718020363Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues.J Org Chem2007https://conductscience.org/library/papers/18020363PubMed
1814530376Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function.J Exp Med2003https://conductscience.org/library/papers/14530376PubMed
1917483872Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity.Cell Mol Life Sci2007https://conductscience.org/library/papers/17483872PubMed
2017372214Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17372214PubMed

See all 97 referencesDownload CSV of references

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.

PMIDTitleJournalYearIn PapersSource
42689115The Cancer Epitope Database and Analysis Resource (CEDAR): current capabilities and future directions.Front Oncol2026https://conductscience.org/library/papers/42689115PubMed
42287230Beyond α-GalCer: Medicinal Chemistry Insights Driving Structural Evolution of CD1d Ligands.J Med Chem2026https://conductscience.org/library/papers/42287230PubMed
40718496CAR-iNKT cells: redefining the frontiers of cellular immunotherapy.Front Immunol2025https://conductscience.org/library/papers/40718496PubMed
40040714Can invariant Natural Killer T cells drive B cell fate? a look at the humoral response.Front Immunol2025https://conductscience.org/library/papers/40040714PubMed
37696892Invariant natural killer T cells in lung diseases.Exp Mol Med2023https://conductscience.org/library/papers/37696892PubMed
37264420A liposomal carbohydrate vaccine, adjuvanted with an NKT cell agonist, induces rapid and enhanced immune responses and antibody class switching.J Nanobiotechnology2023https://conductscience.org/library/papers/37264420PubMed
36460881Role of NKT cells in cancer immunotherapy-from bench to bed.Med Oncol2022https://conductscience.org/library/papers/36460881PubMed
34777358Identification of Two Subsets of Murine DC1 Dendritic Cells That Differ by Surface Phenotype, Gene Expression, and Function.Front Immunol2021https://conductscience.org/library/papers/34777358PubMed
34617070Invariant Natural Killer T cells coordinate removal of senescent cells.Med2021https://conductscience.org/library/papers/34617070PubMed
33371393Influence of Natural Killer Cells and Natural Killer T Cells on Periodontal Disease: A Systematic Review of the Current Literature.Int J Mol Sci2020https://conductscience.org/library/papers/33371393PubMed
31649670Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.Front Immunol2019https://conductscience.org/library/papers/31649670PubMed
30428923A bite so sweet: the glycobiology interface of tick-host-pathogen interactions.Parasit Vectors2018https://conductscience.org/library/papers/30428923PubMed
30013569CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.Front Immunol2018https://conductscience.org/library/papers/30013569PubMed
30013556Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.Front Immunol2018https://conductscience.org/library/papers/30013556PubMed
29576533Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.Cell Chem Biol2018https://conductscience.org/library/papers/29576533PubMed
29520280The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens.Front Immunol2018https://conductscience.org/library/papers/29520280PubMed
29340708Molecular recognition of microbial lipid-based antigens by T cells.Cell Mol Life Sci2018https://conductscience.org/library/papers/29340708PubMed
29018445Natural Killer T Cells in Cancer Immunotherapy.Front Immunol2017https://conductscience.org/library/papers/29018445PubMed
27377623Glycolipid activators of invariant NKT cells as vaccine adjuvants.Immunogenetics2016https://conductscience.org/library/papers/27377623PubMed
27195112Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents.Clin Transl Immunology2016https://conductscience.org/library/papers/27195112PubMed

See all 68 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19945296

GET https://conductscience.org/api/papers/v1/19945296/references?page=2